Penelope Health, a London-based healthtech startup, has secured €87 million ($100 million) in Series B funding to accelerate its mission of simplifying healthcare administration through real-time payer policy intelligence.
The round was led by Thoreau, a HealthTech infrastructure platform, with participation from Bertelsmann Healthcare Investments (BHI), Twine Ventures, and Seedcamp. The investment underscores growing recognition within the European startup ecosystem of the operational inefficiencies plaguing healthcare systems, particularly around insurance coverage determination and administrative workflows.
Addressing Healthcare’s Complexity Gap
Founded in 2025, Penelope Health has developed a platform designed to decode the labyrinthine rules that determine insurance coverage for medical services. The company’s approach addresses a fundamental pain point across the healthcare industry: the opacity and constant evolution of payer policies that force providers to navigate fragmented, outdated, and difficult-to-interpret requirements.
“The rules that determine whether care is covered by insurance are foundational to the healthcare system, yet they remain opaque, fragmented, difficult to interpret, and are constantly changing,” explained Dr. Sohum Patel, Chief Executive Officer of Penelope Health. “Penelope was founded to turn that complexity into a dependable, up-to-date reference that healthcare companies can use in real time.”
The platform currently covers payer policies affecting over 200 million Americans, demonstrating significant market reach and the scale of administrative burden the company seeks to reduce.
Infrastructure Investment and Product Expansion
The newly secured capital will be deployed across two primary objectives. First, Penelope Health plans to develop new products that enhance administrative efficiency for healthcare organisations navigating payer requirements. Second, the company will work alongside Thoreau to construct a shared infrastructure layer facilitating real-time payments and clinical rules processing—a collaborative approach designed to standardise and streamline healthcare transactions across systems.
This partnership signals a broader shift within healthtech toward interoperable solutions that address systemic inefficiencies rather than isolated pain points. By establishing shared infrastructure, both companies aim to reduce duplicate development efforts and create industry standards that benefit the broader ecosystem.
European Healthtech Momentum
Penelope Health’s significant raise reflects sustained investor confidence in European healthtech solutions tackling administrative complexity. The involvement of established healthcare-focused investors like Bertelsmann Healthcare Investments alongside venture capital firms Twine Ventures and Seedcamp demonstrates the sector’s maturation.
The UK startup’s growth also underscores the continued importance of the British healthtech ecosystem, which has maintained momentum despite broader market uncertainties. Solutions addressing healthcare administration—particularly those with potential international application—continue to attract substantial capital as systems globally grapple with rising operational costs and administrative overhead.
As healthcare organisations worldwide prioritise digital transformation and operational efficiency, platforms like Penelope Health represent the intersection of regulatory complexity and technological opportunity that continues to define European healthtech investment patterns.